C.M. Bidwell & Associates’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,310	Closed	-$22K	–	427
2018 Q1	$22K	Hold	9,310	–	–	0.02%	284
2017 Q4	$18K	Buy	+9,310	New	+$18K	0.02%	289